v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 30, 2021   16,636,483        
Balance at beginning of period at Jun. 30, 2021 $ 396,519 $ 167 $ 160,582 $ 240,075 $ (5,819) $ 1,514
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 21,605     21,605    
Cash dividends declared on common stock (2,694)     (2,694)    
Common stock repurchased (in shares)   (675,832)        
Common stock repurchased (19,403) $ (7) (19,396)      
Forfeited restricted stock (in shares)   (9,400)        
Retired stock (in shares)   (2,708)        
Retired stock $ (75)   (75)      
Granted restricted stock (in shares)   0        
Stock issued for RSUs (in shares)   7,118        
Exercised stock options (in shares) 347,800 347,800        
Exercised stock options $ 5,042 $ 3 5,039      
Share-based compensation expense 900   900      
ESOP compensation expense 766   502   264  
Other comprehensive income (loss) (914)         (914)
Balance at end of period (in shares) at Dec. 31, 2021   16,303,461        
Balance at end of period at Dec. 31, 2021 401,746 $ 163 147,552 258,986 (5,555) 600
Balance at beginning of period (in shares) at Sep. 30, 2021   16,307,658        
Balance at beginning of period at Sep. 30, 2021 396,511 $ 163 151,425 249,331 (5,687) 1,279
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 11,078     11,078    
Cash dividends declared on common stock (1,423)     (1,423)    
Common stock repurchased (in shares)   (299,397)        
Common stock repurchased (8,970) $ (3) (8,967)      
Forfeited restricted stock (in shares)   (6,400)        
Exercised stock options (in shares)   301,600        
Exercised stock options 4,342 $ 3 4,339      
Share-based compensation expense 485   485      
ESOP compensation expense 402   270   132  
Other comprehensive income (loss) (679)         (679)
Balance at end of period (in shares) at Dec. 31, 2021   16,303,461        
Balance at end of period at Dec. 31, 2021 $ 401,746 $ 163 147,552 258,986 (5,555) 600
Balance at beginning of period (in shares) at Jun. 30, 2022 15,591,466 15,591,466        
Balance at beginning of period at Jun. 30, 2022 $ 388,845 $ 156 126,106 270,276 (5,290) (2,403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 22,857     22,857    
Cash dividends declared on common stock (2,862)     (2,862)    
Forfeited restricted stock (in shares)   (6,200)        
Retired stock (in shares)   (4,079)        
Retired stock $ (95)   (95)      
Granted restricted stock (in shares)   4,500        
Stock issued for RSUs (in shares)   13,861        
Exercised stock options (in shares) 74,047 74,047        
Exercised stock options $ 1,065 $ 1 1,064      
Share-based compensation expense 1,031   1,031      
ESOP compensation expense 644   380   264  
Other comprehensive income (loss) $ (1,330)         (1,330)
Balance at end of period (in shares) at Dec. 31, 2022 15,673,595 15,673,595        
Balance at end of period at Dec. 31, 2022 $ 410,155 $ 157 128,486 290,271 (5,026) (3,733)
Balance at beginning of period (in shares) at Sep. 30, 2022   15,632,348        
Balance at beginning of period at Sep. 30, 2022 396,222 $ 156 127,153 278,120 (5,158) (4,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 13,658     13,658    
Cash dividends declared on common stock (1,507)     (1,507)    
Forfeited restricted stock (in shares)   (5,800)        
Exercised stock options (in shares)   47,047        
Exercised stock options 677 $ 1 676      
Share-based compensation expense 464   464      
ESOP compensation expense 325   193   132  
Other comprehensive income (loss) $ 316         316
Balance at end of period (in shares) at Dec. 31, 2022 15,673,595 15,673,595        
Balance at end of period at Dec. 31, 2022 $ 410,155 $ 157 $ 128,486 $ 290,271 $ (5,026) $ (3,733)